₹ 1232.4
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT
Target Price
The average target price of DRREDDY.NS is 1244 and suggests 1% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommenda
